Teva CEO Richard Francis Talks Tariffs, Generic Drugs Market

Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld. 

See omnystudio.com/listener for privacy information.